Home
Career Stage
Medical Students Residents Attendings CPT Codes Resources Blog Support

J3246 Tirofiban hcl

J Codes (Drugs)

Also known as: tirofiban, Aggrastat, glycoprotein IIb/IIIa inhibitor

Tirofiban hydrochloride injection is a platelet glycoprotein IIb/IIIa inhibitor used to prevent thrombotic cardiovascular events during coronary intervention.

In Plain Language

blood clot prevention injection; heart intervention medication

Clinical Context

Indicated during percutaneous coronary intervention to prevent acute ischemic complications. Inhibits platelet aggregation. Administered intravenously with loading bolus followed by infusion during and after coronary procedure.

RVU Information

CPT J3246 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.

Billing & Documentation

J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.

Specialties

CardiologyInterventional RadiologyCritical Care

Frequently Asked Questions

What is CPT code J3246?

CPT J3246 (Tirofiban hcl) is a J Codes (Drugs) code. Tirofiban hydrochloride injection is a platelet glycoprotein IIb/IIIa inhibitor used to prevent thrombotic cardiovascular events during coronary intervention.

How is J3246 administered?

CPT J3246 is administered by a healthcare provider, typically via injection or infusion. Indicated during percutaneous coronary intervention to prevent acute ischemic complications. Inhibits platelet aggregation. Administered intravenously with loading bolus followed by infusion during and after coronary procedure. It is used by Cardiology, Interventional Radiology, Critical Care.

When is CPT J3246 used?

Indicated during percutaneous coronary intervention to prevent acute ischemic complications. Inhibits platelet aggregation. Administered intravenously with loading bolus followed by infusion during and after coronary procedure.

Track This Code in RVU Edge

Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.

CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.